Institute of Medical Biometry and Statistics Researchers Add New Findings in the Area of Chronic Obstructive Pulmonary Disease (Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning).

A recent study conducted by researchers at the Institute of Medical Biometry and Statistics explored the associations between comorbidities and specific biomarkers in patients with chronic obstructive pulmonary disease (COPD), with a focus on cardiovascular comorbidities, blood high sensitivity troponin (hs-troponin), and lipid profiles. The study used clinical data from six German University Medical Centres and found that COPD patients with inherited alpha-1-antitrypsin deficiency (AATD) had lower total blood cholesterol levels and fewer cardiovascular comorbidities compared to non-AATD COPD patients. Additionally, the study confirmed that hs-troponin is a suitable predictor of overall mortality in COPD patients. The research suggests that COPD patients with AATD may have a lower cardiovascular risk. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)